- Home
- MAXN vs RANI Comparison
MAXN vs RANI Comparison
Compare MAXN & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAXN
- RANI
- Stock Information
- Founded
- MAXN 2019
- RANI 2012
- Country
- MAXN Singapore
- RANI United States
- Employees
- MAXN N/A
- RANI N/A
- Industry
- MAXN Semiconductors
- RANI Medicinal Chemicals and Botanical Products
- Sector
- MAXN Technology
- RANI Health Care
- Exchange
- MAXN Nasdaq
- RANI Nasdaq
- Market Cap
- MAXN 61.7M
- RANI 55.3M
- IPO Year
- MAXN N/A
- RANI 2021
- Fundamental
- Price
- MAXN $3.05
- RANI $1.39
- Analyst Decision
- MAXN Sell
- RANI Strong Buy
- Analyst Count
- MAXN 6
- RANI 6
- Target Price
- MAXN $195.80
- RANI $11.33
- AVG Volume (30 Days)
- MAXN 178.9K
- RANI 145.1K
- Earning Date
- MAXN 05-29-2025
- RANI 03-31-2025
- Dividend Yield
- MAXN N/A
- RANI N/A
- EPS Growth
- MAXN N/A
- RANI N/A
- EPS
- MAXN N/A
- RANI N/A
- Revenue
- MAXN $689,010,000.00
- RANI $1,028,000.00
- Revenue This Year
- MAXN N/A
- RANI N/A
- Revenue Next Year
- MAXN $34.68
- RANI N/A
- P/E Ratio
- MAXN N/A
- RANI N/A
- Revenue Growth
- MAXN N/A
- RANI N/A
- 52 Week Low
- MAXN $2.68
- RANI $1.20
- 52 Week High
- MAXN $410.00
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- MAXN 35.83
- RANI 46.29
- Support Level
- MAXN $2.76
- RANI $1.20
- Resistance Level
- MAXN $4.26
- RANI $1.56
- Average True Range (ATR)
- MAXN 0.36
- RANI 0.09
- MACD
- MAXN 0.02
- RANI -0.02
- Stochastic Oscillator
- MAXN 19.29
- RANI 52.78
About MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.